OppenheimerFunds’s BeOne Medicines Ltd ONC Stock Holding History

OppenheimerFunds’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$72.7M	Sell	550,988 -23,024	-4%	-$3.11M	0.09%	228
2018 Q4	$80.5M	Buy	574,012 +141,660	+33%	+$18.8M	0.11%	177
2018 Q3	$74.5M	Sell	432,352 -58,511	-12%	-$9.84M	0.09%	252
2018 Q2	$75.5M	Sell	490,863 -82,051	-14%	-$14.6M	0.09%	247
2018 Q1	$96.3M	Sell	572,914 -65,256	-10%	-$8.84M	0.12%	189
2017 Q4	$62.4M	Sell	638,170 -138,670	-18%	-$12.7M	0.08%	271
2017 Q3	$80.4M	Buy	776,840 +61,120	+9%	+$4.55M	0.1%	225
2017 Q2	$32.2M	Buy	715,720 +658,743	+1,156%	+$26M	0.04%	414
2017 Q1	$2.09M	Buy	+56,977	New	+$2.08M	﹤0.01%	935

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

OppenheimerFunds's ONC Position: Q1 2019 in Review

OppenheimerFunds reduced its BeOne Medicines Ltd (ONC) stake by 4% in Q1 2019, selling an estimated $3.11M and leaving 550,988 shares worth $72.7M. The position accounts for 0.09% of the portfolio, ranked #228.

OppenheimerFunds first reported a position in ONC in Q1 2017 and has held it in 9 quarters since. The position peaked at $96.3M in Q1 2018. 199 funds tracked by Wall St. Rank hold ONC as of Q1 2019.

OppenheimerFunds held 550,988 shares of BeOne Medicines Ltd worth $72.7M as of Q1 2019.
OppenheimerFunds sold 23,024 BeOne Medicines Ltd shares in Q1 2019, an estimated $3.11M.
BeOne Medicines Ltd made up 0.09% of OppenheimerFunds's portfolio in Q1 2019, its #228 holding.
OppenheimerFunds first reported a position in BeOne Medicines Ltd in Q1 2017 and has held it in 9 quarters since.
OppenheimerFunds's BeOne Medicines Ltd position peaked at $96.3M in Q1 2018.
199 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.